Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 99 | ECE2024

26th European Congress of Endocrinology

Stockholm, Sweden
11 May 2024 - 14 May 2024

Card image cap
We are pleased to announce that ECE 2024 will be held in Stockholm, Sweden from 11-14 May 2024. We will, once again, be offering the hybrid format next year so you can join us in person in Sweden or remotely with ECE@Home.

Oral Communications

Oral Communications 3: Adrenal and Cardiovascular Endocrinology | Part I

ea0099oc3.1 | Oral Communications 3: Adrenal and Cardiovascular Endocrinology | Part I | ECE2024

Long-term incidence of acute cardiovascular events in transgender people – a large cohort study with national registry data

van Zijverden Lieve , Thijs Abel , van Diemen Jeske , Staphorsius Annemieke , den Heijer Martin , Wiepjes Chantal

Background: Transgender people often use gender-affirming hormone therapy to obtain physical characteristics that comply with their experienced gender. Transgender women use estradiol, usually with anti-androgens. Transgender men use testosterone. It has been reported that gender-affirming hormone therapy is associated with increased risk of acute cardiovascular events, however, this data constitutes largely of low quality evidence. We aimed to investigate the long-term incide...

ea0099oc3.2 | Oral Communications 3: Adrenal and Cardiovascular Endocrinology | Part I | ECE2024

Copeptin and asymptomatic arterial disorder in patients with type 2 diabetes, a cross-sectional study

Davidson Lee Ti , Engvall Jan , Chisalita Simona , Ostgren Carl Johan , Nystrom Fredrik

Background: Individuals with diabetes are at higher risk for developing arterial disorders. The toe-brachial index (TBI) is associated with peripheral vascular disease, and aortic pulse-wave velocity (aPWV) is currently the gold standard for assessing arterial stiffness. High concentrations of plasma arginine vasopressin (AVP) preferentially stimulate V1a receptors, which affect the vascular bed and may contribute to cardiovascular (CV) complications. Copeptin, a more stable p...

ea0099oc3.3 | Oral Communications 3: Adrenal and Cardiovascular Endocrinology | Part I | ECE2024

Inflammation-based scores in patients with pheochromocytoma

Parazzoli Chiara , Prete Alessandro , Favero Vittoria , Aresta Carmen , Pucino Valentina , Ayuk John , Asia Miriam , Elhassan Yasir S , Chiodini Iacopo , Ronchi Cristina L

Background: Pheochromocytoma is associated with systemic inflammation, but the underlying mechanisms are unclear. Hypothesising a putative effect of catecholamines on immune cells, we investigated the relationship between plasma metanephrine levels and haematological parameters – as surrogates for systemic inflammation – in patients with pheochromocytoma. Moreover, we aimed to assess the influence of preoperative α-blockade treatment on the inflammation-based sc...

ea0099oc3.4 | Oral Communications 3: Adrenal and Cardiovascular Endocrinology | Part I | ECE2024

HHEX is required for maintaining circulating glucocorticoid levels through expression of steroid transporter ABCB1 and regulation of lipid droplet homeostasis in the adrenal cortex

Dumontet Typhanie , Basham Katie , Foster Micah , Heard Kyle , Lapensee Christopher , Bothou Christina , Beuschlein Felix , Rainey William , Turcu Adina F. , Lerario Antonio , Hammer Gary

The adrenal cortex synthesizes glucocorticoids that are essential for metabolic homeostasis and modulation of immune responsiveness. Glucocorticoid-producing cells, located in the zona fasciculata (zF), constitute the critical effector of the HPA axis that serves to mediate the mammalian stress response. Dysregulation of glucocorticoid function results in significant morbidity with complete deficiency being incompatible with life. While the zF is composed of heterogenous cell ...

ea0099oc3.5 | Oral Communications 3: Adrenal and Cardiovascular Endocrinology | Part I | ECE2024

Hip fractures in patients with primary aldosteronism – A Swedish nationwide study

Gkaniatsa Eleftheria , Zverkova Sandstrom Tatiana , Rosengren Annika , Trimpou Penelope , Muth Andreas , Johannsson Gudmundur , Ragnarsson Oskar

Objectives: Clinical studies indicate that primary aldosteronism (PA) is associated with dysregulated bone homeostasis. The aim of this study was to evaluate the incidence of hip fractures in patients with PA.Methods: We studied a nationwide cohort of 2419 patients with PA (1997-2019) and 24 187 age and sex matched controls from the general population. Hip fractures were identified by ICD codes in the Swedish National Patient Register. We estimated hazar...

ea0099oc3.6 | Oral Communications 3: Adrenal and Cardiovascular Endocrinology | Part I | ECE2024

Multiple dosing of immediate-release hydrocortisone is associated with a greater risk of hypothalamic-pituitary-adrenal axis suppression when compared to low-dose prednisolone when weaning in steroid-induced adrenal insufficiency

Mifsud Simon , Mifsud Emma Louise , Newell-Price John , Ross Richard , Debono Miguel

Background: Long-term glucocorticoids can result in iatrogenic Cushing’s syndrome with adrenal suppression. Most patients reactivate their hypothalamic-pituitary-adrenal axis once they’re weaned off glucocorticoids. During glucocorticoid withdrawal, many clinicians switch patients to hydrocortisone to benefit from its short half-life1. However, in some patients, hypothalamic-pituitary-adrenal axis recovery is delayed despite the above. It is unclear whethe...